Antiplatelet therapy in interventional cardiology: II. Glycoprotein IIb/IIIa inhibitors.
Jafary
F H
FH
Cardiac Catheterization Laboratory, Division of Cardiology, New England Medical Center, Boston, Massachusetts 02111, USA.
Kimmelstiel
C D
CD
D000789:Angina, Unstable / Q000188:drug therapy* / Q000601:surgery; D015906:Angioplasty, Balloon, Coronary; D004305:Dose-Response Relationship, Drug; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000601:surgery; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D016032:Randomized Controlled Trials as Topic; D015607:Stents; D013921:Thrombocytopenia / Q000139:chemically induced; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D006493:Heparin